MK2-IN-3

CAT: 0804-HY-131249-01Size: 10 mM - 1 mLDry Ice: NoHazardous: No
CAT#:0804-HY-131249-01Size:10 mM - 1 mL
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
MK2-IN-3 is a potent and selective inhibitor of MAPKAP-K2 (MK-2), with an IC50 of 8.5 nM. MK2-IN-3 shows selectivity for MK-2 over MK-3, MK-5, ERK2, MNK1, p38a (IC50s=0.21, 0.081, 3.44, 5.7, and >100 μM, respectively) and MSK1, MSK2, CDK2, JNK2, IKK2 (IC50s>200 μM) . MK2-IN-3 can reduce TNFα production in both U937 cells and in vivo[1].
CAS Number
[724711-21-1]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
MAPKAPK2 (MK2)
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/mk2-in-3.html
Concentration
10mM
Purity
99.70
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O=C1C2=C(NC(C3=CC(C4=CC5=CC=CC=C5N=C4)=NC=C3)=C2)CCN1
Molecular Formula
C21H16N4O
Molecular Weight
340.39
Precautions
H302, H315, H319, H335
References & Citations
[1]Anderson DR, et, al. Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2) . J Med Chem. 2007 May 31;50 (11) :2647-54.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P10072MK2-IN-5
HY-12834-01MK2-IN-1
HY-147283MK2-IN-4
HY-162700MK2-IN-6
HY-179237MK2-IN-8
HY-169513MK2-IN-7
HY-12834A-01MK2-IN-1 (hydrochloride)
HY-P10072A-01MK2-IN-5 (acetate)
HY-168841P38α-MK2-IN-1
HY-W081226-013,3,3-Trifluoropropionyl chloride

Alternative Products

CatalogName
MBS3614353-01MK2-IN-3
MBS5767114MK2-IN-3 hydrate
MBS5804799MK2-IN-4
MBS131247-01MK2-IN-1
ABC-TC0593LLC-MK2
MF-0113744-01MK2-IN-7
MF-0159048-01MK2-IN-5
M11456-01MK2-IN-28
MF-0122401-01MK2-IN-6
TRV-0018797Simian LLC-MK2 Kidney Cells (LLC-MK2)

Popular Products